These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

441 related items for PubMed ID: 1895474

  • 1. Immunoglobulin deficiency and idiotype expression in children developing Haemophilus influenzae type b disease after vaccination with conjugate vaccine. The Collaborative Study Group.
    Holmes SJ, Lucas AH, Osterholm MT, Froeschle JE, Granoff DM.
    JAMA; 1991 Oct 09; 266(14):1960-5. PubMed ID: 1895474
    [Abstract] [Full Text] [Related]

  • 2. The biology of Haemophilus influenzae type b vaccination failure.
    Holmes SJ, Granoff DM.
    J Infect Dis; 1992 Jun 09; 165 Suppl 1():S121-8. PubMed ID: 1588145
    [Abstract] [Full Text] [Related]

  • 3. Immunogenicity of Haemophilus influenzae type b polysaccharide-outer membrane protein conjugate vaccine in patients who acquired Haemophilus disease despite previous vaccination with type b polysaccharide vaccine.
    Granoff DM, Chacko A, Lottenbach KR, Sheetz KE.
    J Pediatr; 1989 Jun 09; 114(6):925-33. PubMed ID: 2786062
    [Abstract] [Full Text] [Related]

  • 4. In vitro induction of IgG1 and IgG2 secretion by B cells of children who developed invasive haemophilus disease despite vaccination.
    Chacko A, Granoff DM.
    Pediatr Res; 1991 Jul 09; 30(1):124-9. PubMed ID: 1891277
    [Abstract] [Full Text] [Related]

  • 5. Immunogenicity of Haemophilus b conjugate vaccine (meningococcal protein conjugate) in children with prior invasive Haemophilus influenzae type b disease.
    Walter EB, Moggio MV, Drucker RP, Wilfert CM.
    Pediatr Infect Dis J; 1990 Sep 09; 9(9):632-5. PubMed ID: 2235187
    [Abstract] [Full Text] [Related]

  • 6. Avidity and bactericidal activity of antibody elicited by different Haemophilus influenzae type b conjugate vaccines. The Vaccine Study Group.
    Schlesinger Y, Granoff DM.
    JAMA; 1992 Mar 18; 267(11):1489-94. PubMed ID: 1538539
    [Abstract] [Full Text] [Related]

  • 7. Effect of immunity to the carrier protein on antibody responses to Haemophilus influenzae type b conjugate vaccines.
    Granoff DM, Rathore MH, Holmes SJ, Granoff PD, Lucas AH.
    Vaccine; 1993 Mar 18; 11 Suppl 1():S46-51. PubMed ID: 8447176
    [Abstract] [Full Text] [Related]

  • 8. Immune response of young children vaccinated with Haemophilus influenzae type b conjugate vaccines.
    Madore DV, Phipps DC, Eby R, Johnson CL, Smith DH.
    Contrib Microbiol Immunol; 1989 Mar 18; 10():125-50. PubMed ID: 2684505
    [No Abstract] [Full Text] [Related]

  • 9. Differences in the immunogenicity of three Haemophilus influenzae type b conjugate vaccines in infants.
    Granoff DM, Anderson EL, Osterholm MT, Holmes SJ, McHugh JE, Belshe RB, Medley F, Murphy TV.
    J Pediatr; 1992 Aug 18; 121(2):187-94. PubMed ID: 1640282
    [Abstract] [Full Text] [Related]

  • 10. A major crossreactive idiotype associated with human antibodies to the Haemophilus influenzae b polysaccharide. Expression in relation to age and immunoglobulin G subclass.
    Lucas AH, Granoff DM.
    J Clin Invest; 1990 Apr 18; 85(4):1158-66. PubMed ID: 2318971
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comparison of naturally acquired and vaccine-induced antibodies to Haemophilus influenzae type b capsular polysaccharide.
    Jelonek MT, Chang SJ, Chiu CY, Park MK, Nahm MH, Ward JI.
    Infect Immun; 1993 Dec 18; 61(12):5345-50. PubMed ID: 8225608
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effect of carrier protein priming on antibody responses to Haemophilus influenzae type b conjugate vaccines in infants.
    Granoff DM, Holmes SJ, Belshe RB, Osterholm MT, McHugh JE, Anderson EL.
    JAMA; 1994 Oct 12; 272(14):1116-21. PubMed ID: 7933324
    [Abstract] [Full Text] [Related]

  • 16. An idiotypic marker associated with a germ-line encoded kappa light chain variable region that predominates the vaccine-induced human antibody response to the Haemophilus influenzae b polysaccharide.
    Lucas AH, Langley RJ, Granoff DM, Nahm MH, Kitamura MY, Scott MG.
    J Clin Invest; 1991 Dec 12; 88(6):1811-8. PubMed ID: 1752943
    [Abstract] [Full Text] [Related]

  • 17. Hemophilus influenzae type B disease in children vaccinated with type B polysaccharide vaccine.
    Granoff DM, Shackelford PG, Suarez BK, Nahm MH, Cates KL, Murphy TV, Karasic R, Osterholm MT, Pandey JP, Daum RS.
    N Engl J Med; 1986 Dec 18; 315(25):1584-90. PubMed ID: 3491315
    [Abstract] [Full Text] [Related]

  • 18. Disease caused by Haemophilus influenzae type b in the immediate period after homologous immunization: immunologic investigation.
    Sood SK, Daum RS.
    Pediatrics; 1990 Apr 18; 85(4 Pt 2):698-704. PubMed ID: 2107522
    [Abstract] [Full Text] [Related]

  • 19. Haemophilus influenzae type b carriage and immunity four years after receiving the Haemophilus influenzae oligosaccharide-CRM197 (HbOC) conjugate vaccine.
    Barbour ML, Booy R, Crook DW, Griffiths H, Chapel HM, Moxon ER, Mayon-White D.
    Pediatr Infect Dis J; 1993 Jun 18; 12(6):478-84. PubMed ID: 8345980
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.